Addus HomeCare (NASDAQ:ADUS) Issues Quarterly Earnings Results

Addus HomeCare (NASDAQ:ADUS) announced its earnings results on Monday. The company reported $1.73 EPS for the quarter, beating analysts’ consensus estimates of $1.70 by $0.03, FiscalAI reports. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The firm had revenue of $377.41 million for the quarter, compared to analysts’ expectations of $376.24 million.

Addus HomeCare Stock Performance

Shares of ADUS traded up $1.31 during mid-day trading on Monday, hitting $116.79. 241,517 shares of the company traded hands, compared to its average volume of 244,794. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83. Addus HomeCare has a 1 year low of $87.95 and a 1 year high of $124.43. The stock has a market cap of $2.18 billion, a price-to-earnings ratio of 21.59, a P/E/G ratio of 1.58 and a beta of 0.87. The stock has a 50-day moving average price of $101.68 and a two-hundred day moving average price of $101.40.

Insider Buying and Selling at Addus HomeCare

In other news, insider Heather Brianne Dixon sold 288 shares of the firm’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the transaction, the insider directly owned 44,371 shares in the company, valued at $4,160,668.67. This trade represents a 0.64% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 788 shares of company stock worth $73,506. 4.10% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Royal Bank of Canada grew its stake in shares of Addus HomeCare by 24.3% during the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock valued at $682,000 after purchasing an additional 1,347 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Addus HomeCare by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after purchasing an additional 459 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Addus HomeCare by 6.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after buying an additional 2,952 shares during the last quarter. Jane Street Group LLC boosted its holdings in shares of Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock worth $1,092,000 after buying an additional 8,780 shares during the last quarter. Finally, Intech Investment Management LLC grew its position in Addus HomeCare by 44.7% during the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock valued at $1,420,000 after buying an additional 4,439 shares during the period. Institutional investors own 95.35% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Citigroup reaffirmed a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Citizens Jmp reaffirmed a “market outperform” rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Monday, May 18th. Finally, Barclays boosted their target price on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a report on Wednesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $131.50.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.